Lineage Cell Therapeutics, Inc.
LCTX
$0.49
-$0.01-2.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.81M | 32.71M | 38.50M | 43.62M | 35.49M |
| Total Receivables | 638.00K | 405.00K | 235.00K | 77.00K | 745.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.55M | 1.29M | 1.66M | 2.02M | 2.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 51.00M | 34.40M | 40.39M | 45.72M | 38.44M |
|
|
|||||
| Total Current Assets | 51.00M | 34.40M | 40.39M | 45.72M | 38.44M |
| Net Property, Plant & Equipment | 4.40M | 4.38M | 4.60M | 4.96M | 4.77M |
| Long-term Investments | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M |
| Goodwill | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M |
| Total Other Intangibles | 46.54M | 46.54M | 46.54M | 46.54M | 46.56M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 614.00K | 606.00K | 598.00K | 596.00K | 577.00K |
| Total Assets | 113.22M | 96.59M | 102.80M | 108.48M | 101.02M |
|
|
|||||
| Total Accounts Payable | 1.17M | 1.60M | 2.39M | 2.21M | 2.05M |
| Total Accrued Expenses | 4.26M | 2.88M | 2.63M | 3.47M | 4.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.15M | 1.14M | 1.12M | 1.10M | 882.00K |
| Total Finance Division Other Current Liabilities | 7.39M | 8.25M | 9.14M | 10.11M | 10.81M |
| Total Other Current Liabilities | 7.39M | 8.25M | 9.14M | 10.11M | 10.81M |
| Total Current Liabilities | 13.98M | 13.86M | 15.28M | 16.89M | 17.96M |
|
|
|||||
| Total Current Liabilities | 13.98M | 13.86M | 15.28M | 16.89M | 17.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.36M | 1.61M | 1.84M | 2.15M | 2.07M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.87M | 16.32M | 18.82M | 18.45M | 18.97M |
| Total Liabilities | 36.21M | 31.80M | 35.93M | 37.49M | 39.00M |
|
|
|||||
| Common Stock & APIC | 484.72M | 469.27M | 467.93M | 466.57M | 451.34M |
| Retained Earnings | -403.47M | -400.19M | -397.16M | -391.40M | -384.86M |
| Treasury Stock & Other | -2.88M | -2.89M | -2.47M | -2.77M | -3.07M |
| Total Common Equity | 78.38M | 66.19M | 68.30M | 72.40M | 63.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 78.38M | 66.19M | 68.30M | 72.40M | 63.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.37M | -1.39M | -1.43M | -1.41M | -1.40M |
| Total Equity | 77.01M | 64.79M | 66.88M | 70.99M | 62.02M |
|
|
|||||
